Biotest Aktiengesellschaft Cash Flow-to-Debt Ratio
Biotest Aktiengesellschaft cash flow-to-debt ratio. Biotest Aktiengesellschaft (BIO3) has a Cash Flow-to-Debt Ratio of -0.06x as of March 2025, meaning its operating cash flow of €-58.10 Million could theoretically repay 0% of its total liabilities (€906.90 Million) in one year. Check Biotest Aktiengesellschaft cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Biotest Aktiengesellschaft (2002–2024)
Cash flow-to-debt ratio of Biotest Aktiengesellschaft from 2002 to 2024. Historical debt coverage capacity for Biotest Aktiengesellschaft across 23 annual periods. Check cash flow quality index of Biotest Aktiengesellschaft to evaluate the quality of earnings relative to operating cash generation.
Biotest Aktiengesellschaft Cash Flow-to-Debt Ratio by Year (2002–2024)
Biotest Aktiengesellschaft cash flow-to-debt ratio by year from 2002 to 2024. Year-by-year debt coverage analysis for Biotest Aktiengesellschaft. For the full cash flow conversion analysis, see BIO3 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | €60.90 Million | €903.30 Million | ▲ +2377.3% |
| 2023 | 0.00x | €-2.70 Million | €912.00 Million | ▲ +93.9% |
| 2022 | -0.05x | €-40.50 Million | €831.90 Million | ▼ -203.9% |
| 2021 | 0.05x | €33.90 Million | €723.80 Million | ▲ +293.4% |
| 2020 | -0.02x | €-16.70 Million | €689.70 Million | ▲ +54.5% |
| 2019 | -0.05x | €-33.60 Million | €631.50 Million | ▲ +41.8% |
| 2018 | -0.09x | €-50.00 Million | €547.10 Million | ▼ -268.0% |
| 2017 | 0.05x | €34.30 Million | €630.70 Million | ▼ -52.8% |
| 2016 | 0.12x | €65.90 Million | €572.10 Million | ▲ +66.4% |
| 2015 | 0.07x | €38.10 Million | €550.40 Million | ▲ +435.4% |
| 2014 | -0.02x | €-11.40 Million | €552.40 Million | ▼ -22.0% |
| 2013 | -0.02x | €-7.20 Million | €425.80 Million | ▼ -115.2% |
| 2012 | 0.11x | €34.73 Million | €312.91 Million | ▼ -48.4% |
| 2011 | 0.22x | €72.28 Million | €336.09 Million | ▼ -10.3% |
| 2010 | 0.24x | €77.83 Million | €324.73 Million | ▲ +175.1% |
| 2009 | 0.09x | €31.68 Million | €363.59 Million | ▼ -14.4% |
| 2008 | 0.10x | €34.49 Million | €338.67 Million | ▼ -2.6% |
| 2007 | 0.10x | €32.51 Million | €310.94 Million | ▼ -22.6% |
| 2006 | 0.14x | €26.31 Million | €194.69 Million | ▼ -5.5% |
| 2005 | 0.14x | €28.32 Million | €198.12 Million | ▲ +41.5% |
| 2004 | 0.10x | €25.29 Million | €250.31 Million | ▲ +50.9% |
| 2003 | 0.07x | €16.52 Million | €246.69 Million | ▲ +610.6% |
| 2002 | 0.01x | €2.46 Million | €261.20 Million | — |